These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11922650)

  • 1. Interference of two common European digital cellular phones with implantable cardioverter-defibrillators.
    Niehaus M; Gille R; Cierpka R; Korte T; Tebbenjohans J
    Eur Heart J; 2002 Apr; 23(7):586-8; dicussion 588. PubMed ID: 11922650
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillators.
    Chiladakis JA; Davlouros P; Agelopoulos G; Manolis AS
    Eur Heart J; 2001 Aug; 22(15):1337-42. PubMed ID: 11465966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Editorial comment: mobile telephones and implantable cardioverter-defibrillators].
    Demirkan D
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):49. PubMed ID: 12793432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can a person with a pacemaker use and receive calls via a cellular telephone?].
    Passchier WF
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):490. PubMed ID: 10766600
    [No Abstract]   [Full Text] [Related]  

  • 5. Digital cellular telephones and ICDs.
    Santini M
    Eur Heart J; 2001 Aug; 22(15):1251-2. PubMed ID: 11465959
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable rhythm devices and electromagnetic interference: myth or reality?
    Dyrda K; Khairy P
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):823-32. PubMed ID: 18570620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implanted devices and electromagnetic interference: case presentations and review.
    Snow JS; Kalenderian D; Colasacco JA; Jadonath RL; Goldner BG; Cohen TJ
    J Invasive Cardiol; 1995 Mar; 7(2):25-32. PubMed ID: 10155711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment?
    Napp A; Stunder D; Maytin M; Kraus T; Marx N; Driessen S
    Eur Heart J; 2015 Jul; 36(28):1798-804. PubMed ID: 25908772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AANA Journal Course: update for nurse anesthetists. Arrhythmia management devices and electromagnetic interference.
    Mattingly E
    AANA J; 2005 Apr; 73(2):129-36. PubMed ID: 15835833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment.
    Goldschlager N; Epstein A; Friedman P; Gang E; Krol R; Olshansky B;
    Arch Intern Med; 2001 Mar; 161(5):649-55. PubMed ID: 11231696
    [No Abstract]   [Full Text] [Related]  

  • 12. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of patients with implantable cardioverter defibrillators.
    Donnelly P; Pal N; Herity NA
    Ulster Med J; 2007 May; 76(2):66-7. PubMed ID: 17476818
    [No Abstract]   [Full Text] [Related]  

  • 14. [Do mobile telephones have adverse effects on the functions of implantable cardioverter defibrillators?].
    Tandoğan I; Ileri M; Yetkin E; Temizhan A; Aras D; Sezgin AT; Biyikoğlu F; Saşmaz A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):45-8, AXVII. PubMed ID: 12101794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillators and cellular telephones: is there any interference?
    Occhetta E; Plebani L; Bortnik M; Sacchetti G; Trevi G
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):983-9. PubMed ID: 10456625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vitro evaluation of electromagnetic interference between implantable cardiac devices and ophthalmic laser systems.
    Sher NA; Golben MP; Kresge K; Selznick L; Adabag S
    Europace; 2011 Apr; 13(4):583-8. PubMed ID: 21252191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPad2(R) use in patients with implantable cardioverter defibrillators causes electromagnetic interference: the EMIT Study.
    Kozik TM; Chien G; Connolly TF; Grewal GS; Liang D; Chien W
    J Am Heart Assoc; 2014 Apr; 3(2):e000746. PubMed ID: 24721802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does ultrasonic dental equipment affect cardiovascular implantable electronic devices?
    Stoopler ET; Sia YW; Kuperstein AS
    J Can Dent Assoc; 2011; 77():b113. PubMed ID: 21884651
    [No Abstract]   [Full Text] [Related]  

  • 19. What's the difference between a pacemaker and an implantable cardioverter defibrillator (ICD)?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682906
    [No Abstract]   [Full Text] [Related]  

  • 20. Pacemakers and implantable cardioverter defibrillators.
    Allen M
    Anaesthesia; 2006 Sep; 61(9):883-90. PubMed ID: 16922756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.